Journal articleEndocr Relat Cancer2023
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
- Journal
- Endocr Relat Cancer
- Published
- 13 September 2023
- Citations
- 8
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 1
- Its registry lists this paper as resultsTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell C… NCT01010126↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.